Cosmos Health Inc. (COSM)
NASDAQ: COSM · Real-Time Price · USD
0.2709
+0.0242 (9.81%)
At close: Jun 4, 2026, 4:00 PM EDT
0.2807
+0.0098 (3.62%)
After-hours: Jun 4, 2026, 7:58 PM EDT
Cosmos Health Revenue
Cosmos Health had revenue of $17.93M in the quarter ending March 31, 2026, with 30.74% growth. This brings the company's revenue in the last twelve months to $69.49M, up 29.75% year-over-year. In the year 2025, Cosmos Health had annual revenue of $65.27M with 19.93% growth.
Revenue (ttm)
$69.49M
Revenue Growth
+29.75%
P/S Ratio
0.21
Revenue / Employee
$426,302
Employees
163
Market Cap
14.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.27M | 10.85M | 19.93% |
| Dec 31, 2024 | 54.43M | 1.05M | 1.97% |
| Dec 31, 2023 | 53.38M | 3.03M | 6.02% |
| Dec 31, 2022 | 50.35M | -5.89M | -10.48% |
| Dec 31, 2021 | 56.24M | 833.40K | 1.50% |
| Dec 31, 2020 | 55.41M | 15.73M | 39.65% |
| Dec 31, 2019 | 39.68M | 2.59M | 6.99% |
| Dec 31, 2018 | 37.08M | 7.07M | 23.56% |
| Dec 31, 2017 | 30.01M | 23.26M | 344.28% |
| Dec 31, 2016 | 6.76M | 6.22M | 1,165.53% |
| Dec 31, 2015 | 533.80K | -7.11M | -93.01% |
| Dec 31, 2014 | 7.64M | 6.74M | 746.55% |
| Dec 31, 2013 | 902.37K | - | - |
| Dec 31, 2012 | - | - | - |
| Jul 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| McKesson | 403.43B |
| Cencora | 328.68B |
| Cardinal Health | 250.74B |
| Henry Schein | 13.38B |
| Accendra Health | 2.72B |
| 111, Inc. | 1.80B |
| Synergy CHC | 27.70M |
| Cellyan Biotechnology | 16.36M |
COSM News
- 8 hours ago - Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz - GlobeNewsWire
- 14 hours ago - Cosmos Health explores monetization of non-core assets - TheFly
- 14 hours ago - Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value - GlobeNewsWire
- 3 days ago - Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657 - GlobeNewsWire
- 9 days ago - Cosmos Health says targeting $200M in revenue by 2029 - TheFly
- 9 days ago - Cosmos Health sees FY26 revenue surpassing $90M, one est. $87.3M - TheFly
- 9 days ago - Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation - GlobeNewsWire
- 14 days ago - Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants - Accesswire